Thromb Haemost 1990; 63(01): 122-126
DOI: 10.1055/s-0038-1645697
Original Article
Schattauer GmbH Stuttgart

Localization of von Willebrand Factor and Thrombin-Interactive Domains on Human Platelet Glycoprotein Ib

Yashuiro Katagiri
1   The Department of Cardiovascular Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Yaeko Hayashi
1   The Department of Cardiovascular Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Kazuo Yamamoto
1   The Department of Cardiovascular Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Kenjiro Tanoue
1   The Department of Cardiovascular Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
,
Goro kosaki
*   Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
,
Hiroh Yamazaki
1   The Department of Cardiovascular Research, The Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
› Author Affiliations
Further Information

Publication History

Received 25 July 1989

Accepted after revision29 October 1989

Publication Date:
02 July 2018 (online)

Summary

Platelet membrane glycoprotein Ib (GPIb) functions as receptors for thrombin and von Willebrand factor (vWF) in the presence of ristocetin. To precisely locate the domains on GPIb interacting with vWF and thrombin, we prepared several peptides that have amino acid sequences analogous to that ol the GPIb α-chain and examined their effects on ristocetin-induced (vWFdependent) and thrombin-induced platelet aggregations. A peptide extending from residues Asp235 to Lys262 showed the strongest inhibitory effect on ristocetin-induced platelet agglutination, and a group of overlapping peptides composed of 24-28 amino acid residues representing sequences extending from Phe216 to Asp274 was found to inhibit platelet aggregation induced by thrombin. Other peptides did not inhibit platelet aggregations. Moreover the binding to platelets of the monoclonal anti-GPIb antibody (TM60) which had been shown to inhibit both ristocetin- and thrombin-induced platelet aggregations was strongly inhibited by a peptide extending from Asp249 to Asp274. These data demonstrate that the vWF-hinding domain exists in a small region between residues Asp235 and Lys262; the thrombin-interacting domain, in contrast, is located between residues Phe216 and Ala274, with a possible center of interaction in the sequence from Phe216 to Thr240 on the GPIb α-chain, and thrombin binding requires a relatively strict conformation in this domain.

 
  • References

  • 1 Clemetson KJ. Biochemistry of platelet membrane glycoproteins. In Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry, and Pathology. Jamieson GA. ed Alan R Liss; New York: 1988: 33-075
  • 2 Okumura T, Jamieson GA. Platelet glycocalicin: A single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res 1976; 8: 701-706
  • 3 Okumura T, Hasitz M, Jamieson GA. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem 1978 253. 3435-3443
  • 4 Wicki AN, Clemetson KJ. Structure and function of platelet membrane glycoprotein lb and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem 1985; 153: 1-11
  • 5 Handa M, Titani K, Holland LZ, Roberts JK, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein lb. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986; 261: 12579-12585
  • 6 Wicki AN, Clemetson KJ. The glycoprotein lb complex of human blood platelets. Eur J Biochem 1987; 163: 43-50
  • 7 Yamamoto K, Yamamoto N, Kitagawa H, Tanoue K, Kosaki G, Yamuzuki H. Localization of a thrombiin-binding she on human platelet membrane glycoprotein lb determined by a monoclonal antibody. Thromb Haemostas 1986; 55: 162-167
  • 8 Kerndt MC, Du X, Booth WJ. Ristocetin dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633-640
  • 9 Lopez JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the α-chain of human platelet glycoprotein lb: A transmembrane protein with homology to leucine-rich α2 -glycoprotein. Proc Natl Acad Sci USA 1987; 84: 5615-5619
  • 10 Lopez JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ. The α- and β-chains of human platelet glycoprotein lb are both transmembrane proteins containing a leucine-rich amino acid sequence.. Proc Natl Acad Sci USA 1988; 85: 2135-2139
  • 11 Clemetson KJ, Naim HY, Luscher EF. Relationship between glycocalicin and glycoprotein lb of human platelets. Proc Natl Acad Sci USA 1981; 78: 2712-2716
  • 12 Titani K, Takio K, Handa M, Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein lb. Proc Natl Acad Sci USA 1987; 84: 5610-4
  • 13 Yamamoto N, Kitagawa H, Tanoue K, Yamazaki H. Monoclonal antibody to glycoprotein lb inhibits both thrombin- and ristocetininduced platelet aggregations. Thromb Res 1985; 39: 751-759
  • 14 Olson JD, Brockway WJ, Fass DN, Bowie EJ W, Mann KG. Purification of porcine and human ristocetin-Willebrand factor. J Lab Clin Med 1977; 89: 1278-1294
  • 15 Yamamoto N, Kitagawa H, Yamamoto K, Tanoue K, Yamazaki H. Calcium ions and the conformation of glycoprotein Ilia that is essential for fibrinogen binding to platelets: Analysis by a new monoclonal anti-GPIIIa antibody, TM83. Blood 1989; 73: 1552-1560
  • 16 Pytela R, Pierschbacher MD, Rouslahti E. Identification and isolation of a 140kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985; 40: 191-198
  • 17 Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238: 1132-1134
  • 18 Vicente V, Kostel PJ, Ruggeri ZM. Isolation and functional characterization of the von Willebrand factor-binding domain located between residue His1-Arg293 of the α-chain of glycoprotein lb. J Biol Chem 1988; 263: 18473-18479
  • 19 Mao SJ T, Yates MT, Owen TJ, Krstcnansky JL. Interaction of hirudin with thrombin: Identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry 1988; 27: 8170-8173
  • 20 Gartner TK, Bennett jS. The tetrapeptide analogue of the cell attachment she of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 1985; 260: 11891-11894
  • 21 Tam SW, Fenton WJ, II Detwilei TC. Platelet thrombin receptor.. Binding of α-thrombin is coupled to signal generation by a ehymotrypsin-sensitive mechanism. J Biol Chem 1980; 255: 6626-6632
  • 22 Jung SM, Moroi M. Crosslinking of platelet glycoprotein lb by N succinimidyl(4-azidophenyldithio)propionate and 3,3’-dithiobis(sulfosuccinimidylpropionate).. Biochim Biophys Acta 1983; 761: 152-162
  • 23 Takamatsu J, Horne III MK, Gralnick JR. Identification of the thrombin receptor on human platelets by chemical crosslinking. J Clin Invest 1986; 77: 362-368
  • 24 Jandrot-Perrus M, Didry D, Guillin M-C, Nurden A. Cross-linking of alpha- and gamma-thrombin to distinct binding sites on human platelets. Eur J Biochem 1988; 174: 359-367